TickerFactsScreenerDevelopers

Jazz Pharmaceuticals plc (JAZZ) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2008: $24.90M2009: $15.60M2010: $44.79M2011: $82.08M2012: $387.20M2013: $636.50M2014: $684.04M2015: $988.78M2016: $365.96M2017: $386.04M2018: $309.62M2019: $637.34M2020: $1.06B2021: $591.45M2022: $881.48M2023: $1.51B2024: $2.41B2025: $1.39B$1.39B
2008Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$1.39B-42.3%
2024$2.41B+60.2%
2023$1.51B+70.9%
2022$881.48M+49.0%
2021$591.45M-44.1%
2020$1.06B+66.0%
2019$637.34M+105.8%
2018$309.62M-19.8%
2017$386.04M+5.5%
2016$365.96M-63.0%
2015$988.78M+44.6%
2014$684.04M+7.5%
2013$636.50M+64.4%
2012$387.20M+371.8%
2011$82.08M+83.2%
2010$44.79M+187.2%
2009$15.60M-37.4%
2008$24.90M—